Absolute bioavailability is the fraction of an administered extravascular drug amount that reaches systemic circulation unchanged, relative to an intravenous reference. Intravenous administration is conventionally assigned 100% bioavailability.
Bioavailability
Absolute bioavailability is the fraction of an administered extravascular drug amount that reaches systemic circulation unchanged, relative to an intravenous reference. Intravenous administration is conventionally assigned 100% bioavailability.
\(F = (AUC_{\mathrm{extravascular}}/AUC_{\mathrm{IV}}) \times (Dose_{\mathrm{IV}}/Dose_{\mathrm{extravascular}})\)
What this formula means
Scientific principle
Principle
After extravascular administration, a drug may not be completely absorbed and may undergo presystemic metabolism. Bioavailability quantifies the systemic exposure obtained relative to an intravenous reference after accounting for dose differences.
Derivation
For linear pharmacokinetics, systemic exposure after IV administration is proportional to Dose_IV/CL.
For extravascular administration, exposure is proportional to F × Dose_extravascular/CL.
Therefore, AUC_extravascular = F × Dose_extravascular/CL.
For IV administration, AUC_IV = Dose_IV/CL.
Divide the two expressions and rearrange.
The resulting relationship is F = (AUC_extravascular/AUC_IV) × (Dose_IV/Dose_extravascular).
Final Result
F = (AUC_extravascular/AUC_IV) × (Dose_IV/Dose_extravascular). For IV administration, F = 1 or 100% by convention.
Variables and their meanings
F
Absolute bioavailability.
AUCextravascular
Area under the concentration-time curve after extravascular administration.
AUCIV
Area under the concentration-time curve after intravenous administration.
Dose IV
Amount administered intravenously in the comparison.
Doseextravascular
Amount administered by an extravascular route.
SI units and conversions
F
Dimensionless fraction or percentage.
AUC
mg·h·L⁻¹.
Dose
mg or μg.
Conditions of use
The IV and extravascular measurements should be comparable.
Dose differences must be accounted for.
Linear pharmacokinetics should apply over the studied dose range.
AUC measurements should represent comparable exposure intervals.
The compared formulations and study conditions should be appropriately controlled.
Limitations and assumptions
Bioavailability can vary with formulation, food, gastrointestinal conditions and metabolism.
AUC comparisons can be affected by nonlinear pharmacokinetics.
Absolute bioavailability requires a suitable IV reference.
Bioavailability does not directly describe the rate of absorption.
High bioavailability does not necessarily mean that a drug is more effective or safer.
Step-by-step worked examples
| Problem | Solution | Answer |
|---|---|---|
In a theoretical pharmacokinetic study, an extravascular formulation produces an AUC of 40 mg·h·L⁻¹. The IV reference produces an AUC of 80 mg·h·L⁻¹. Both comparison amounts are equal. Calculate absolute bioavailability. |
| Absolute bioavailability is 50%. |
A theoretical comparison uses an extravascular amount of 200 mg and an IV amount of 100 mg. Their measured AUC values are 30 and 40 mg·h·L⁻¹ respectively. Calculate absolute bioavailability. |
| Absolute bioavailability is 37.5%. |
Real-world applications
Comparing oral and intravenous drug exposure.
Evaluating pharmaceutical formulations.
Studying absorption and first-pass metabolism.
Supporting bioavailability research.
Understanding systemic drug exposure.
Formula Meaning
Absolute bioavailability is the fraction of an administered extravascular drug amount that reaches systemic circulation unchanged, relative to an intravenous reference. Intravenous administration is conventionally assigned 100% bioavailability.
Sources and further reading
No source has been supplied for this item yet. Treat the claim as needing editorial verification.